Natural eye protein "clusterin" may hold key to treating dry eye

For millions of patients suffering from dry eye symptoms, relief may be found in a natural tear protein. New research brings to light a possible new therapy in treating dry eye syndrome symptoms. Clusterin is a protein that occurs naturally in tears and acts to protect cells and proteins. Researchers theorized that clusterin is depleted in dry eyes and that by replenishing the protein would be helpful. What they didn't realize that clusterin also seals the ocular surface barrier and protects the surface from additional damage. With promising pre-clinical results, researchers are hopeful that developing clusterin as a biological drug will provide an effective treatment for dry eye as well as corneal disorders. While there are no drugs currently on the market to address ocular surface disruption, VisiVite's patented Dry Eye Relief TG-1000 helps to support a healthy tear film.*